» Articles » PMID: 26137654

Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction

Overview
Journal Isr Med Assoc J
Specialty General Medicine
Date 2015 Jul 4
PMID 26137654
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hyperhomocysteinemia is associated with increased cardiovascular risk, but treatment with folic acid has no effect on outcome in unselected patient populations.

Objectives: To confirm previous observations on the association of homozygosity for the TT MTHFR genotype with B12 deficiency and endothelial dysfunction, and to investigate whether patients with B12 deficiency should be tested for 677MTHFR genotype.

Methods: We enrolled 100 individuals with B12 deficiency, tested them for the MTHFR C677T polymorphism and measured their homocysteine levels. Forearm endothelial function was checked in 23 B12-deficient individuals (13 with TT MTHFR genotype and 10 with CT or CC genotypes). Flow-mediated dilatation (FMD) was tested after short-term treatment with B12 and folic acid in 12 TT MTHFR homozygotes.

Results: Frequency of the TT MTHFR genotype was 28/100 (28%), compared with 47/313 (15%) in a previously published cohort of individuals with normal B12 levels (P = 0.005). Mean homocysteine level was 21.2 ± 16 μM among TT homozygotes as compared to 12.3 ± 5.6 μM in individuals with the CC or CT genotype (P = 0.008). FMD was abnormal ( 6%) in 9/13 TT individuals with B12 deficiency (69%), and was still abnormal in 7/12 of those tested 6 weeks after B12 and folic treatment (58%).

Conclusions: Among individuals with B12 deficiency, the frequency of the TT MTHFR genotype was particularly high. The TT polymorphism was associated with endothelial dysfunction even after 6 weeks of treatment with B12 and folic acid. Based on our findings we suggest that B12 deficiency be tested for MTHFR polymorphism in order to identify potential vascular abnormalities and increased cardiovascular risk.

Citing Articles

MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings.

Giammarco S, Chiusolo P, Maggi R, Rossi M, Minnella G, Metafuni E Ann Hematol. 2024; 103(10):3973-3977.

PMID: 39196375 PMC: 11512882. DOI: 10.1007/s00277-024-05937-z.


Detection of Methylene Tetrahydrofolate Reductase (MTHFR C677T) Mutation among Acute Lymphoblastic Leukemia in Sudanese Patients.

Mohieldeen W, Ahmed A, Elmosaad Y, Suliman R, Alfahed A, Hjazi A Rep Biochem Mol Biol. 2024; 12(3):458-464.

PMID: 38618256 PMC: 11015921. DOI: 10.61186/rbmb.12.3.458.


Cumulative visual impact of two coagulability disorders: A case report.

Stanca H, Tabacaru B, Balta F, Malaescu M, Stanca S, Munteanu M Exp Ther Med. 2020; 20(6):218.

PMID: 33149782 PMC: 7604761. DOI: 10.3892/etm.2020.9348.


Food Intervention with Folate Reduces TNF-α and Interleukin Levels in Overweight and Obese Women with the C677T Polymorphism: A Randomized Trial.

Lisboa J, Ribeiro M, Luna R, Lima R, do Nascimento R, Monteiro M Nutrients. 2020; 12(2).

PMID: 32019154 PMC: 7071147. DOI: 10.3390/nu12020361.


The Many Faces of Cobalamin (Vitamin B) Deficiency.

Wolffenbuttel B, Wouters H, Heiner-Fokkema M, van der Klauw M Mayo Clin Proc Innov Qual Outcomes. 2019; 3(2):200-214.

PMID: 31193945 PMC: 6543499. DOI: 10.1016/j.mayocpiqo.2019.03.002.